ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.309,13
0,02%
Dow Jones
39.821,72
0,04%
Euro vs US Dollar
1,08545
-0,05%
Bitcoin
69.770,86
-2,35%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX
  6. Willow Biosciences Inc (WLLW)

  7. Willow Biosciences Inc (WLLW) News

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:WLLW
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202413h00PR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
13/05/202413h00PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATETSX:WLLWWillow Biosciences Inc
29/03/202400h30PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
29/03/202400h30PR Newswire (US)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
01/03/202400h00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
01/03/202400h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
21/02/202400h00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
21/02/202400h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
31/01/202413h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
31/01/202413h00PR Newswire (Canada)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
16/01/202413h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
16/01/202413h00PR Newswire (Canada)WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
10/01/202413h00PR Newswire (US)WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023TSX:WLLWWillow Biosciences Inc
10/01/202413h00PR Newswire (Canada)WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023TSX:WLLWWillow Biosciences Inc
07/12/202313h00PR Newswire (US)WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
07/12/202313h00PR Newswire (Canada)WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
11/10/202301h52PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
11/10/202301h52PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
03/10/202313h00PR Newswire (US)WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONTSX:WLLWWillow Biosciences Inc
03/10/202313h00PR Newswire (Canada)WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONTSX:WLLWWillow Biosciences Inc
03/10/202309h00PR Newswire (US)WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONTSX:WLLWWillow Biosciences Inc
12/09/202313h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
06/09/202313h00PR Newswire (Canada)WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCATSX:WLLWWillow Biosciences Inc
06/09/202313h00PR Newswire (US)WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCATSX:WLLWWillow Biosciences Inc
30/08/202313h00PR Newswire (US)WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTTSX:WLLWWillow Biosciences Inc
30/08/202313h00PR Newswire (Canada)WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTTSX:WLLWWillow Biosciences Inc
24/08/202313h00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORMTSX:WLLWWillow Biosciences Inc
24/08/202313h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORMTSX:WLLWWillow Biosciences Inc
21/08/202313h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
21/08/202313h00PR Newswire (Canada)WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
 Showing the most relevant articles for your search:TSX:WLLW

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
TG
ALV
Allianz
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
TG
DTE
Deutsche Telekom
TG
NOV
Novo Nordisk
TG
BAYN
Bayer
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten